CURRENT STATUS OF IMMUNOTHERAPY TRIALS IN ANIMALS

被引：0
|
作者：
MACEWEN, EG
HAYES, AA
HARVEY, HJ
MOONEY, S
PATNAIK, A
HARDY, WD
机构：
来源：
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 1979年 / 175卷 / 06期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [41] Update on the current status of peptide immunotherapy
    Larche, Mark
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) : 906 - 909
  • [42] The current status of immunotherapy in peritoneal carcinomatosis
    Stroehlein, Michael Alfred
    Heiss, Markus Maria
    Jauch, Karl-Walter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1019 - 1027
  • [43] Current Status and Perspectives of the Immunotherapy of Leishmaniasis
    El-On, Joseph
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (10): : 623 - 628
  • [44] CURRENT STATUS OF MELANOMA CHEMOTHERAPY AND IMMUNOTHERAPY
    CZARNETZKI, BM
    MACHER, E
    BEHRENDT, H
    LEJEUNE, F
    RECENT RESULTS IN CANCER RESEARCH, 1982, 80 : 264 - 268
  • [45] Current status of immunotherapy for cancer treatment
    Wolf, D.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (04) : 190 - 192
  • [46] Immunotherapy: Current Status and Future Perspectives
    Charalampos S. Floudas
    Gagandeep Brar
    Tim F. Greten
    Digestive Diseases and Sciences, 2019, 64 : 1030 - 1040
  • [47] Current status of immunotherapy in gastrointestinal malignancies
    Lorenzen, Sylvie
    Lordick, Florian
    Loosen, Sven Heiko
    Tacke, Frank
    Trautwein, Christian
    Roderburg, Christoph
    Ettrich, Thomas J.
    Perkhofer, Lukas
    Reinacher-Schick, Anke
    Stein, Alexander
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (06): : 542 - 555
  • [48] Current challenges in designing GBM trials for immunotherapy
    Weathers, Shiao-Pei
    Gilbert, Mark R.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (03) : 331 - 337
  • [49] Current challenges in designing GBM trials for immunotherapy
    Shiao-Pei Weathers
    Mark R. Gilbert
    Journal of Neuro-Oncology, 2015, 123 : 331 - 337
  • [50] Status of current trials and potential future trials with sparsentan
    Trachtman, Howard
    Komers, Radko
    Inrig, Jula
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (03) : 145 - 147
12345